000			02009 a2200601 4500
005			20250516001136.0
264		0	_c20110509
008			201105s 0 0 eng d
022			_a1879-0852
024	7		_a10.1016/j.ejca.2010.07.009 _2doi
040			_aNLM _beng _cNLM
100	1		_aKaufmann, M
245	0	0	_aFirst-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial. _h[electronic resource]
260			_bEuropean journal of cancer (Oxford, England : 1990) _cDec 2010
300			_a3184-91 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntimetabolites, Antineoplastic _xadministration & dosage
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aBreast Neoplasms, Male _xdrug therapy
650	0	4	_aCapecitabine
650	0	4	_aDeoxycytidine _xadministration & dosage
650	0	4	_aDisease Progression
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Metastasis
650	0	4	_aProspective Studies
650	0	4	_aQuality of Life
700	1		_aMaass, N
700	1		_aCosta, S D
700	1		_aSchneeweiss, A
700	1		_aLoibl, S
700	1		_aSütterlin, M W
700	1		_aSchrader, I
700	1		_aGerber, B
700	1		_aBauer, W
700	1		_aWiest, W
700	1		_aTomé, O
700	1		_aDistelrath, A
700	1		_aHagen, V
700	1		_aKleine-Tebbe, A
700	1		_aRuckhaeberle, E
700	1		_aMehta, K
700	1		_avon Minckwitz, G
773	0		_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 46 _gno. 18 _gp. 3184-91
856	4	0	_uhttps://doi.org/10.1016/j.ejca.2010.07.009 _zAvailable from publisher's website
999			_c20131661 _d20131661